Component portfolio and prices
On this page:
- Barcodes for updating LIMS for apheresis platelets in platelet additive solution (PAS) and plasma
- Component portfolio
- Component and transport prices
- Non stock and special components, including components for urgent requests
Component portfolio
Portfolio of blood components and guidance for their clinical use (PDF 1MB)
This provides details of therapeutic blood components including constituents, and information on:
- specifications
- identification barcodes
- quality standards and monitoring
- storage and handling
- clinical indications and contraindications
- specialist requirements
- dosage, administration, recognition of adverse effects
- material safety data sheet
Apheresis platelets in PAS and plasma
Apheresis platelets in platelet additive solution (PAS) and plasma is a new component and should not be confused with the existing component, apheresis platelets in additive solution, also known as washed platelets.
Operational validation at a single collection site, the Leeds donation centre, will take place towards the end of this summer and will start with an end-to-end test of the process. This will enable us to issue this component, with limited availability during the single site trial, to hospitals from September this year.
Use the barcodes here to update LIMS: identification barcodes (PDF 29KB) by the end of July 2025.
Component and transport prices
Non stock and special components, including components for urgent requests
It is important you allow for processing and transport time when ordering these components
- Refer to Appendix 7 in the Portfolio of blood components. Download the pdf using the link at the top of this page.